Journal article
Stem Cell Therapy in Neonatal Diseases
Indian journal of pediatrics, v 82(7), pp 637-641
01 Jul 2015
PMID: 25804318
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Common complications in neonates occur in almost every organ system in the neonatal intensive care unit. While a number of them have short-term effects, a few of them also have long-term consequences. Among the latter are bronchopulmonary dysplasia and necrotizing enterocolitis in premature neonates, and hypoxic ischemic encephalopathy in borderline preterm and term neonates. While medical advances have improved our understanding of the pathogenesis, therapies to effectively prevent and/or significantly ameliorate the severity of these disorders, and to decrease their associated mortality and morbidity have not been found. One promising approach to make a potential impact in the outcomes of these neonatal conditions is the use stem cells, specifically, mesenchymal stem cells. The authors briefly review the potential role of stem cell therapy in the above-mentioned neonatal diseases. They focus primarily on human clinical trials.
Metrics
Details
- Title
- Stem Cell Therapy in Neonatal Diseases
- Creators
- Ciprian P. Gheorghe - Yale UniversityVineet Bhandari - Drexel University
- Publication Details
- Indian journal of pediatrics, v 82(7), pp 637-641
- Publisher
- Springer Nature
- Number of pages
- 5
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000358904900011
- Scopus ID
- 2-s2.0-84931573712
- Other Identifier
- 991019167450304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Pediatrics